Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Duyun Maojian tea forest enters spring harvest season in China's Guizhou 2024-03-22 18:59
The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for Metastatic NSCLC were Published in Cell Reports Medicine 2024-03-22 18:42
Frost & Sullivan Launches the 2024 Edition of India Manufacturing Excellence and Sustainability 4.0 Awards 2024-03-22 18:30
Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline 2024-03-22 18:00
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001 2024-03-22 08:00
NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy 2024-03-22 08:00
OcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth 2024-03-21 22:44
Ping An Reports RMB117,989 million of Operating Profit Attributable to Shareholders of the Parent Company in 2023, cash dividend increased for 12 consecutive years 2024-03-21 21:10
Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved 2024-03-21 19:47
More Middle-Aged and Older Men Are Seeking Male Breast Reduction In Singapore, says Dr Ivan Puah 2024-03-21 18:08
Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients 2024-03-21 16:00
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
SINGAPORE'S "HUSTLE CULTURE" TAKES ITS TOLL: THE AIR STATION AND RESMED LAUNCH INITIATIVE TO ADDRESS WORK-INDUCED SLEEP ISSUES 2024-03-21 09:35
TreeFrog's Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) 2024-03-21 07:30
Jiangsu Recbio Technology Co., Ltd. announced 2023 annual results report and latest progress 2024-03-21 00:22
Sisram Medical Announces 2023 Annual Results 2024-03-20 21:53
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study 2024-03-20 20:30
Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia 2024-03-20 20:30
Innovent Announces 2023 Annual Results and Business Updates 2024-03-20 19:44
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m 2024-03-20 19:10
1 69 70 71 72 73 810